Promega Corporation

Screen for Calpain Inhibitors Using a Cell-Based, High-Throughput Assay

  • Share
  • Print
  • Email
  • Article

Abstract

We developed a cell-based assay for endogenous calpain activity using a cell-permeant luminescent calpain substrate. Using the protocol described here, we were able to identify potent, reproducible inhibitors of calpain activity in a high-throughput screening application.

Cell Notes 18, 6–8.

Katheleen Seyb1,2, Jake Ni1, Mickey Huang1, Eli Schuman1, Mary L. Michaelis2 and Marcie A. Glicksman1

1Laboratory for Drug Discovery in Neurodegeneration, Harvard Center for Neurodegeneration and Repair, Brigham and Women's Hospital, 2Department of Pharmacology and Toxicology, University of Kansas
2007
  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.